Fed Circuit to address cannabis clash

05-07-2022

Fed Circuit to address cannabis clash

Ralf Liebhold / Shutterstock.com

The dispute centres on a process for extracting CBD from cannabis plant material, which anticipates the use of CBD as an anti-epileptic treatment.


Canopy Growth, GW Pharma, Federal Circuit, cannabis, CBD, patent infringement

More on this story

Canopy sues GW Pharma over cannabis patent
24-12-2020

LSIPR